IN THE NEWS

THE LATEST NEWS

UCB Enters Drug Discovery Collaboration with Aitia

Research Identifies Potential New Biomarkers of Atherosclerotic Coronary Artery Disease

Becoming Aitia: Why GNS Shifted from AI Provider to Drug Discoverer

New Biomarkers for Atherosclerosis Found Using Digital Twins

The Milken Institute Future of Health Summit – “Is AI Just What the Doctor-or Patient-Ordered?” Panel Discussion

Intelligent Technology Brings Companies To A New Moment Of Truth

Colin Hill Opening Keynote at the Annual Merck Technology Symposium 2022

How AI is helping “drug hunters” succeed – GNS Co-founder, Iya Khalil talk on CNN

Panel Discussion | Why the FDA will bet more on in silico simulations to trigger better success rates for NDAs

BIO 2022: Push to model disease biology advancing, but slowly